NCT00416598 2019-02-19Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid LeukemiaNational Cancer Institute (NCI)Phase 2 Completed546 enrolled 5 charts